Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors

J Am Acad Dermatol. 2015 Apr;72(4):741-3. doi: 10.1016/j.jaad.2014.07.065.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biological Therapy / adverse effects*
  • Communicable Diseases / complications*
  • Communicable Diseases / diagnosis*
  • Humans
  • Skin Diseases / complications*
  • Skin Diseases / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Tumor Necrosis Factor-alpha